Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP8 | P40818 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13848549 | 0.81 | HTT (0.35) | USP8HTTALDH1A1GAANQO1 | |
| SCHEMBL5728527 | 0.77 | ALDH1A1 (0.38) | USP8CYP2D6ALDH1A1GAANQO1 | |
| SCHEMBL13349444 | 0.77 | APOBEC3A (0.40) | CYP2D6HTTALDH1A1APOBEC3AAPOBEC3G | |
| SCHEMBL9765300 | 0.76 | CYP1A1 (0.38) | USP8CYP2D6ALDH1A1GAANQO1 | |
| SCHEMBL3687105 | 0.76 | SLC6A4 (0.44) | CYP2D6HTTALDH1A1GAANQO1 | |
| SCHEMBL13848578 | 0.76 | SMN1; SMN2 (0.42) | HTTALDH1A1GAAGLAKDM4E | |
| SCHEMBL13078047 | 0.73 | KDM4E (0.46) | ALDH1A1GAANQO1GLAKDM4E | |
| SCHEMBL16518004 | 0.72 | CYP2D6 (0.40) | CYP2D6HTTALDH1A1GAANQO1 | |
| SCHEMBL11933957 | 0.72 | CYP1B1 (0.44) | CYP2D6ALDH1A1APOBEC3AAPOBEC3GKDM4E | |
| SCHEMBL16472139 | 0.71 | CYP2D6 (0.42) | CYP2D6HTTAPOBEC3AAPOBEC3GCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7563816-B2 | Ophthalmic compositions for treating ocular hypertension | MERCK & CO. INC. (US) | 2009-07-21 | — | — | US | disclosed |
| US-20080032951-A1 | Ophthalmic Compositions For Treating Ocular Hypertension | MERCK SHARP & DOHME CORP. | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080032951-A1 | Ophthalmic Compositions For Treating Ocular Hypertension | KCNH2, KCNN1, KCNH3 | USP8 4451/4885CYP2D6 4138/4885HTT 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.